Primary contribution of the injector to carryover of a trace analyte in high-performance liquid chromatography

Trace detection of glycolic acid by electrophore labeling gas chromatography-electron capture mass spectrometry

As little as 10 pg of standard glycolic acid (glycolate) was detected in a method comprising the following sequence of steps: (1) add glycolate-2,2-d(2) as an internal standard and exchange the carboxylate oxygens in hot HCl/[(18)O]water; (2) form an amide derivative with a water-soluble carbodiimide and the electrophoric amine, AMACE1; (3) purify by bypass HPLC; (4) derivatize the residual hydroxy with butyric anhydride; (5) partition with acetonitrile/2 M NaCl; and (6) detect by GC-ECMS. At an intermediate stage in method development, 1 pg of glycolate-2,2,-d(2) could be detected by subjecting it to the above steps 2-6, forming product in an overall, absolute yield of 76%. Step 1 was added after an effort to fully overcome background contamination by glycolate was unsuccessful. For example, background contamination by glycolate could increase rather than decrease when the methanol reagent in the procedure was "carefully purified." The work extends the sensitivity for glycolate detection by approximately 100-fold and provides high-performance conditions for the analytical steps employed.

Bypass high-performance liquid chromatography for purification of trace analytes

technique that we have termed "bypass HPLC" is introduced as a noncontaminating way to define the retention time of a trace analyte for purification purposes on an HPLC column when the amount of the analyte in real samples is too low for on-line detection. The technique employs two HPLC columns ("calibration" and "purification") of the same type that are connected in parallel, with appropriate valving, along with use of two accessory compounds. By injecting ordinary (on-line detectable) amounts of authentic analyte plus the two accessory compounds on the calibration column, and similarly the two accessory compounds onto the purification column, one can predict the retention of the analyte on the latter column without contaminating this column, as follows. The migration times of the first accessory compound provide a reference time on each column; the migration times of the second accessory compound are normalized on each column by subtracting the corresponding reference times; and then the retention time of analyte can be calculated on the second column since the ratio of its normalized retention times on the two columns equals the corresponding ratio for the second accessory compound.

Analysis of 3,N(4)-ethenocytosine in DNA and in human urine by isotope dilution gas chromatography/negative ion chemical ionization/mass spectrometry

The promutagenic etheno DNA adducts have been detected in tissue DNA of rodents and humans from various exogenous and endogenous sources. While other etheno DNA adducts have been detected and quantified by isotope dilution gas chromatography/negative ion chemical ionization/mass spectrometry (GC/NICI/MS), similar analysis for 3,N(4)-ethenocytosine (epsilonCyt) has not been available. In this report, a GC/NICI/MS assay was developed for detection and quantification of epsilonCyt in DNA and in human urine samples. The stable isotope of epsilonCyt with 7 mass units higher than the normal epsilonCyt was synthesized and used as internal standard of the assay. The adduct-enriched fraction of DNA hydrolysate was derivatized with pentafluorobenzyl bromide before GC/NICI/MS analysis with selective ion monitoring at [M - 181](-) fragments of pentafluorobenzylated epsilonCyt and its isotope analogue. One femtogram (S/N > 40) of pentafluorobenzylated epsilonCyt was detected when injected on column with selective ion monitoring mode. The limit of quantification for the entire assay was 7.4 fmol of epsilonCyt, which was approximately one thousand times lower than that of the HPLC/fluorescence assay for the nucleoside 3,N(4)-etheno-2'-deoxycytidine in DNA. Analysis of chloroacetaldehyde-treated calf thymus DNA by both GC/NICI/MS and HPLC/fluorescence methods provided similar adduct levels and thus verified the assay. This GC/NICI/MS method was used for analysis of epsilonCyt in two smokers' urine samples and the average level of epsilonCyt was 101 +/- 17 pg/mL/g of creatinine. Thus, quantification of epsilonCyt in DNA and in urine by this highly specific and ultrasensitive isotope dilution GC/NICI/MS assay may facilitate research on the role of epsilonCyt in carcinogenesis and in cancer development.

Electron-capture mass spectrometry: recent advances

Electron-capture (EC) is a sensitive and selective ionization technique for mass spectrometry (MS). In the most familiar form of EC, a susceptible analyte (electrophore) is detected after eluting from a gas chromatography (GC) column, where a low attomole detection limit for standards is routine. High-performance liquid chromatography can facilitate sample cleanup prior to detection by GC-EC-MS, but carryover and shifts in retention time for the "invisible" analyte can be difficulties. Solid-phase extraction avoids these difficulties, but the degree of cleanup and recovery can be problems. Alternative electrophoric derivatizing reagents are available to help deal with interferences, and new reagents such as "AMACE1" are emerging. Releasable forms of electrophores can be used as tags for labeling macromolecules, motivated by the desire to multiplex ligand-type assays. The conventional, gas-phase ion source for EC is not well-understood, especially the role of wall reactions. Using an electron monochromator to tune the electron energy adds to the selectivity and information provided by EC-MS. High-resolution and tandem EC-MS measurements are emerging. Electron-capture dissociation is a new technique to sequence small- to medium-sized peptides, having the advantage of providing more extensive sequence information relative to other MS techniques. Particle-beam EC-MS tends to be less sensitive than GC-EC-MS, but not always. Recently it was demonstrated that EC-MS can be accomplished on an ordinary laser desorption time-of-flight mass spectrometer, and also by using atmospheric pressure chemical ionization. Two applications are discussed here in detail: bile acids and oxidized phenylalanine. EC-MS is well-established as a useful technique for trace analysis in special cases, and the scope of its usefulness is broadening (qualitative analysis and detection of more polar and larger molecules), based on advances in both the chemical and instrumental aspects of this technique.

A gas chromatography/electron capture/negative chemical ionization high-resolution mass spectrometry method for analysis of endogenous and exogenous N7-(2-hydroxyethyl)guanine in rodents and its potential for human biological monitoring

A gas chromatography/electron capture/negative chemical ionization high-resolution mass spectrometry (GC/EC/NCI-HRMS) method was developed for quantitating N7-(2-hydroxyethyl)guanine (N7-HEG) with excellent sensitivity and specificity. [4,5,6,8-(13)C(4)]-N7-HEG was synthesized, characterized, and quantitated using HPLC/electrospray ionization mass spectrometry (HPLC/ESI-MS) so it could serve as an internal standard. After being converted to its corresponding xanthine and derivatized with pentafluorobenzyl (PFB) bromide twice, the PFB derivative of N7-HEG was characterized using GC/EC/NCI-HRMS carried out at full scan mode. The most abundant fragment was at m/z 555, with a molecular formula of C(21)H(9)N(4)O(3)F(10), resulting from the loss of one PFB group. By monitoring m/z 555.0515 (analyte) and m/z 559.0649 (internal standard), this assay demonstrated a linear relationship over a range of 1 fmol to 1 pmol of N7-HEG versus 20 fmol of [(13)C(4)]-N7-HEG on column. The limit of detection (LOD) for the complete assay was 600 amol (S/N = 5) injected on column. The variation of this assay was within 15% from 1 to 20 fmol of N7-HEG versus 2 fmol of [(13)C(4)]-N7-HEG with four replications for each calibration standard. Two hundred to three hundred micrograms of spleen DNA of control rats and mice and 100 microg of spleen DNA of rats and mice exposed to 3000 ppm ethylene for 6 h/day for 5 days were analyzed using GC/EC/NCI-HRMS. The amounts of N7-HEG varied from 0.2 to 0.3 pmol/micromol of guanine in tissues of control rats. Ethylene-exposed animals had 5-15-fold higher N7-HEG levels than controls. This assay was able to quantitate N7-HEG in 25-30 microg of DNA from human lymphocytes with excellent specificity. This was due in part to human tissues having 10-15-fold higher amounts of endogenous N7-HEG than rodents. These results show that this GC/EC/NCI-HRMS method is highly sensitive and specific and can be used in biological monitoring and molecular dosimetry and molecular epidemiology studies.

General method for determining ethylene oxide and related N7-guanine DNA adducts by gas chromatography-electron capture mass spectrometry

A 112-micrograms sample of DNA was spiked with 103 pg of N7-(2'-hydroxyethyl)guanine and 100 pg of N7-(2'-hydroxyethyl-d4)guanine, the internal standard. The sample was subjected to the following sequence of steps: heating at 100 degrees C, precipitation of the DNA with HCl, reaction with nitrous acid to form the corresponding xanthines, reaction twice with pentafluorobenzyl bromide (first to derivatize NH, then OH), solid-phase extraction on silica and detection by gas chromatography-electron capture mass spectrometry. The absolute, overall yield of final product for both the analyte and internal standard was 9.7%. Conveniently, the three chemical reactions are conducted sequentially in the same vial and, aside from a washing step, are separated only by evaporations. Corresponding N7-guanine methyl, phenyl and styrene oxide adducts were detected at about the 50-ng level by the procedure, to indicate the generality of the method.

Measurement of angiotensin II: use of two injectors to minimize HPLC shadowing

We investigated the use of two HPLC injectors, one reserved for standards and the other for blanks or biological samples, to minimize shadowing in the measurement of angiotensin II (ANGII). HPLC carryover of standard ANGII to blank with a one-injector and a two-injector system were 47.0 +/- 5.0 and 2.4 +/- 0.5 fmol/ml, respectively, a 19.6-fold reduction. Measured normal canine left ventricular myocardium ANGII level by the two-injector HPLC-RIA system was 22.3 +/- 2.4 fmol/g, with a signal-to-noise ratio of 11.7, an improved signal-to-noise ratio of 29.3 fold vs. the one injector. This innovation reduced the incidence of false-positive ANGII results, and thus can be applied to other compounds that exhibit HPLC-derived shadowing.